Authors:
Bonifati, V
De Michele, G
Lucking, CB
Durr, A
Fabrizio, E
Ambrosio, G
Vanacore, N
De Mari, M
Marconi, R
Capus, L
Breteler, MMB
Gasser, T
Oostra, B
Wood, N
Agid, Y
Filla, A
Meco, G
Brice, A
Citation: V. Bonifati et al., The parkin gene and its phenotype, NEUROL SCI, 22(1), 2001, pp. 51-52
Authors:
Ruitenberg, A
Skoog, I
Ott, A
Aevarsson, O
Witteman, JCM
Lernfelt, B
van Harskamp, F
Hofman, A
Breteler, MMB
Citation: A. Ruitenberg et al., Blood pressure and risk of dementia: Results from the Rotterdam study and the Gothenburg H-70 study, DEMENT G C, 12(1), 2001, pp. 33-39
Authors:
McDonnell, J
Redekop, WK
van der Roer, N
Goes, E
Ruitenberg, A
Busschbach, JJV
Breteler, MMB
Rutten, FFH
Citation: J. Mcdonnell et al., The cost of treatment of Alzheimer's disease in the Netherlands - A regression-based simulation model, PHARMACOECO, 19(4), 2001, pp. 379-390
Authors:
Klungel, OH
Stricker, BHC
Breteler, MMB
Seidell, JC
Psaty, BM
de Boer, A
Citation: Oh. Klungel et al., Is drug treatment of hypertension in clinical practice as effective as in randomized controlled trials with regard to the reduction of the incidence of stroke?, EPIDEMIOLOG, 12(3), 2001, pp. 339-344
Authors:
Sijens, PE
den Heijer, T
de Leeuw, FE
de Groot, JC
Achten, E
Heijboer, RJJ
Hofman, A
Breteler, MMB
Oudkerk, M
Citation: Pe. Sijens et al., MR spectroscopy detection of lactate and lipid signals in the brains of healthy elderly people, EUR RADIOL, 11(8), 2001, pp. 1495-1501
Authors:
van de Vijver, DAMC
Stricker, BHC
Breteler, MMB
Roos, RAC
Porsius, AJ
de Boer, A
Citation: Damc. Van De Vijver et al., Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease, PHARM WORLD, 23(4), 2001, pp. 148-152
Authors:
Dermaut, B
Roks, G
Theuns, J
Rademakers, R
Houwing-Duistermaat, JJ
Serneels, S
Hofman, A
Breteler, MMB
Cruts, M
Van Broeckhoven, C
van Duijn, CM
Citation: B. Dermaut et al., Variable expression of presenilin 1 is not a major determinant of risk forlate-onset Alzheimer's Disease, J NEUROL, 248(11), 2001, pp. 935-939
Authors:
del Sol, AI
Moons, KGM
Hollander, M
Hofman, A
Koudstaal, PJ
Grobbee, DE
Breteler, MMB
Witteman, JCM
Bots, ML
Citation: Ai. Del Sol et al., Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam study, STROKE, 32(7), 2001, pp. 1532-1538
Citation: Jc. De Groot et Mmb. Breteler, Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study - Reply from the authors, NEUROLOGY, 57(11), 2001, pp. 2149-2149
Authors:
de Groot, JC
de Leeuw, FE
Oudkerk, M
Hofman, A
Jolles, J
Breteler, MMB
Citation: Jc. De Groot et al., Cerebral white matter lesions and subjective cognitive dysfunction - The Rotterdam Scan Study, NEUROLOGY, 56(11), 2001, pp. 1539-1545
Authors:
de Leeuw, FE
de Groot, JC
Achten, E
Oudkerk, M
Ramos, LMP
Heijboer, R
Hofman, A
Jolles, J
van Gijn, J
Breteler, MMB
Citation: Fe. De Leeuw et al., Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study, J NE NE PSY, 70(1), 2001, pp. 9-14
Authors:
Hak, AE
Pols, HAP
Stehouwer, CDA
Meijer, J
Kiliaan, AJ
Hofman, A
Breteler, MMB
Witteman, JCM
Citation: Ae. Hak et al., Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: The Rotterdam study, J CLIN END, 86(9), 2001, pp. 4398-4405
Authors:
Sijens, PE
den Heijer, T
de Leeuw, FE
de Groot, JC
Achten, E
Heijboer, RJJ
Hofman, A
Breteler, MMB
Oudkerk, M
Citation: Pe. Sijens et al., Human brain chemical shift imaging at age 60 to 90 - Analysis of the causes of the observed sex differences in brain metabolites, INV RADIOL, 36(10), 2001, pp. 597-603
Authors:
Periquet, M
Lucking, CB
Vaughan, JR
Bonifati, V
Durr, A
De Michele, G
Horstink, MW
Farrer, M
Illarioshkin, SN
Pollak, P
Borg, M
Brefel-Courbon, C
Denefle, P
Meco, G
Gasser, T
Breteler, MMB
Wood, NW
Agid, Y
Brice, A
Citation: M. Periquet et al., Origin of the mutations in the parkin gene in europe: Exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects, AM J HU GEN, 68(3), 2001, pp. 617-626